Exploration of glycosyltransferases mutation status in cervical cancer reveals PARP14 as a potential prognostic marker.

导出 OA

翻译打印收藏纠错

作者： Hui,Wang ^[1] ; Shen,Luo ^[1] ; Xin,Wu ^[1] ; Yuanyuan,Ruan ^[2] ; Ling,Qiu ^[1] ; Hao,Feng ^[1] ; Shurong,Zhu ^[1] ; Yanan,You ^[1] ; Ming,Li ^[1] ; Wenting,Yang ^[3] ; Yanding,Zhao ^[4] ; Xiang,Tao ^[1] ; Hua,Jiang ^[5]

作者单位： Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200090, China. ^[1] Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China. ^[2] Shanghai Genenexus healthcare technology company, Shanghai, 200433, China. ^[3] Department of Molecular and Systems Biology, The Geisel School of Medicine at Dartmouth, 03756, Lebanon, NH, USA. ^[4] Obstetrics & Gynecology Hospital of Fudan University, Shanghai, 200090, China. jianghua@fudan.edu.cn. ^[5]

关键词 Cervical Cancer Glycosyltransferase (GT)Mutation PARP14 (poly (ADP-ribose) polymerase member 14)

主题词女(雌)性(Female);人类(Humans);聚ADP核糖聚合酶类(Poly(ADP-ribose) Polymerases);宫颈肿瘤(Uterine Cervical Neoplasms);糖基转移酶类(Glycosyltransferases);预后(Prognosis);突变(Mutation)

DOI 10.1007/s10719-023-10134-7

PMID 37650946

发布时间 2023-11-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交